Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

News.

Here you will find information and news about the latest events around the CARL System. In this way, you can stay
‘a heartbeat ahead’ of developments.

Also available as RSS feed for your RSS feed reader.

You can subscribe to our newsletter here:

CARL in Lisbon: 11th Congress of the EuroELSO
04/20/23

The 11th Congress of the European Extracorporeal Life Support Organization (EuroELSO) will be held from April 26 to April 29 at the Congress Center in Lisbon.

Learn more >
Successful satellite symposium at the annual meeting of the DGTHG in Hamburg
04/20/23

This February it was finally time again: After a two-year break in attendance due to the Covid pandemic, the Annual Meeting of the German Society for Thoracic Cardiac and Vascular Surgery (DGTHG) and the 54th Annual Meeting of the German Society for Pediatric Cardiology and Congenital Heart Defects (DGPK) could take place live again.

Learn more >
“Reducing fears and uncertainty through practice”
04/20/23

Check, call, press: Anyone can save lives by lay resuscitation. We spoke with Patricia Niemietz, CARL Support staff member and former nurse in the field of intensive care medicine, about the topic of lay resuscitation, fears about the right technique and establishing lay resuscitation in schools.

Learn more >
ISICEM: CARL attracts international attention
04/20/23

Europe, Australia and the USA: Visitors to the International Symposium on Intensive Care and Emergency Medicine in Brussels (ISICEM) travelled from all over the world to learn and exchange information about the latest topics in intensive care and emergency medicine. “The congress motto “We care intensively” gave us the perfect template to discuss our vision of saving lives after cardiac arrest together with the emergency teams and intensivists on site,” said Thomas Kraft, CEO of Resuscitec.

Learn more >
“Dealing with sudden cardiac death: We are taking the next step in extracorporeal resuscitation.”
12/21/22

Thomas Kraft has been Chairman and CEO of Resuscitec GmbH since the beginning of October 2022 and took functional responsibility for Sales, Marketing and the Medical Alliance. We spoke to him about his first months at the company, CARL’s unique selling points and his vision for the future of Resuscitec GmbH.

Learn more >
Business delegation from Vietnam visits Resuscitec GmbH
12/21/22

Business delegation from Vietnam visits Resuscitec GmbH On 19 October, Resuscitec GmbH hosted visitors from Vietnam: 20 members of a business delegation came to the company’s premises in Freiburg. The meeting was organized by the IHK Exportakademie GmbH, which had invited the delegation to Germany as part of the manager training programme of the Federal…

Learn more >
Interdisciplinary exchange at the DIVI22
12/21/22

The 22nd Congress of the German Interdisciplinary Association for Intensive Care and Emergency Medicine (DIVI) in Hamburg was well attended with about 5,700 participants – and another complete success for CARL. The CARL Teams from the Sales and Support departments of Resuscitec GmbH once again presented the technical performance features of the CARL System live to many interested parties at the CARL booth in the Congress Center Hamburg from 30 November to 2 December.

Learn more >
One year of clinical experience at CARL. Recap – Focus Meeting Heart in Münster
12/21/22

During the lunch symposium “CARL. Recap – Latest clinical experience reports and results from one year of CARL” at this year’s Focus Meeting Heart from 4 to 6 November in Münster, more than 75 participants were informed about the latest clinical application experiences for controlled whole-body reperfusion. 

Learn more >
For the first time – the ECPR School in Prague
12/21/22

More than 300 international medical experts met for the first time at the ECPR School conference in Prague at the end of October to exchange experiences. This new conference format is supported by a specially established ECPR working group of EuroELSO, which is entirely dedicated to the development of extracorporeal therapies in emergency medicine.

Learn more >
CARL. Year 1: Successful start into the marketing
12/21/22

CARL. Year 1: Successful start into the marketing After many preparations and the successfully passed CE certification, the CARL System was launched at the beginning of 2022. In addition to setting up study centers to implement the multicenter PMCF registry study, renowned reference hospitals could already be gained as CARL users in this first year.…

Learn more >